Ординатура / Офтальмология / Английские материалы / Assessing and Treating Glaucoma in Children of the Developing World_Helveston, Smallwood_2009
.pdf
ORBIS International
Assessing and Treating
Glaucoma in Children
of the Developing World
Assessing and Treating
Glaucoma in Children of the Developing World
Gordon R. Douglas MD, Alex Levin MD, Daniel E. Neely MD,
and David S. Walton MD
This manual is part of a series of specialized manuals produced by ORBIS Telemedicine, Cyber-Sight.
Edited by:
Eugene M. Helveston, MD
Lynda M. Smallwood
This document is for those who wish to learn more about how to deal with the pediatric glaucomas and whose resources may not always be at the highest level. The authors’ aim is to inform and to encourage eye doctors to deliver the best level of care possible for these children, but we also recognize everything advised here may not be possible to accomplish in their location. Any equipment limitations should not discourage doctors from using all resources available to them, to the best of their abilities.
© April 2009
Table of Contents
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Basic Principles for Management of Glaucoma in Children . . . . . . . . . . . . . . . . . . 7
Problems and Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Long Term Resource Planning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
General Characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Causes of Childhood Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Childhood Glaucoma: Signs, Age of Onset, Prognosis . . . . . . . . . . . . . . . . . . . . .11
Infantile Primary “Congenital” Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
Infantile Aphakic Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
Examination Under Anesthesia (EUA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
General Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13 Equipment for EUA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14
Seven Steps in the Conduct of the Examination Under Anesthesia . . . . . . . . . |
.15 |
Step 1: Cornea and Anterior Segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
.16 |
Step 2: Intraocular Pressure (IOP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
.17 |
Step 3: Posterior Segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
.17 |
Step 4: Gonioscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
.18 |
Step 5: Supplemental Examinations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
18 |
Step 6: Diagnostic Paradigm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
18 |
Step 7: EUA Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
19 |
Medical Treatment of the Pediatric Glaucomas . . . . . . . . . . . . . . . . . . . . . . . . . . .19
Surgical Treatment of the Pediatric Glaucomas . . . . . . . . . . . . . . . . . . . . . . . . . . .20
General Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20
Goniotomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20
Trabeculotomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25
Trabeculectomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28
Tube Implant Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29
Cycloablation Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33
Introduction
Glaucoma in children or even young adults cannot be looked upon in the same way as glaucoma in the adult. Diagnostic and treatment methods used primarily in adults may not be appropriate for the pediatric glaucomas. Children are not small adults so their disease must be assessed and treated accordingly. Diagnosis and treatment of pediatric glaucomas must take into consideration the age and developmental status of the child, other systemic signs, family history, the family psychosocial situation, and, in particular; the availability of follow-up and ongoing care. For those with internet access, a model for support and education for families can be found through the
Pediatric Glaucoma and Cataract Family Association (www.pgcfa.org). Assistance for doctors treating children with glaucoma is available through ORBIS Telemedicine,
Cyber-Sight at www.cybersight.org.
For glaucoma treatment, there is an inherent assumption that “success” is achieved in the patient who lives life with useful vision. More specifically, this might be called the purpose of treatment for the pediatric glaucomas. In children, life span may be many years past the initial diagnosis (life expectancy 37.2 years in Zambia and 83.2 years in Andorra!); thus, the expected series of examinations and therapies through those years must address a number of issues and challenges that are not seen generally in an adult population.
Overview
Basic Principles for Management of Glaucoma in Children
vThe initial treatment may not be successful for the lifespan of the patient. A plan for the child must be formulated, or at least appreciated by the first as well as subsequent doctors, so as to utilize ALL options in a logical & optimal sequence.
vProcedures done early should be planned not to interfere with, nor compromise the potential success of subsequent procedures.
vIt must be recognized that each surgical intervention may have accompanying or potential future complications, many of which may not be apparent for months to years afterward (e.g. retinal detachments, macular edema, endophthalmitis, etc).
The extended life expectancy of the pediatric glaucoma patient will mean that these events, which might not be seen in adults, are more likely to appear over an extended time period. Short-term studies (< 5-10 years), therefore, may not be as useful in planning longer or lifetime surgical options.
vA significant part of treating pediatric glaucomas is awareness of the need for timely diagnosis and appropriate treatment of strabismus, refractive amblyopia and media opacities (cornea and lens). Even in successfully treated cases of pediatric glaucoma, these factors have a profound impact upon the degree of vision loss and therefore should not be overlooked.
7
vMany pediatric glaucomas are associated with other conditions and diseases, which must be considered during diagnosis and treatment (e.g. retinoblastoma, cataracts in rubella, corneal decompensation in aniridia, proptosis in neurofibromatosis, developmental delay in Lowe syndrome, etc.).
vPediatric glaucoma is a family disease, which can affect other members directly by genetic transmission and indirectly by the demands of follow-up and care.
One principle that is in common with both childhood and adult glaucoma is the importance of early detection and appropriate intervention!
Problems & Purpose
The ophthalmologist who is responsible for these children and young adults with glaucoma must inform the patients and their parents about the numerous potential problems associated with pediatric glaucoma. This includes emphasizing the importance of lifelong supervision and watchfulness for eye problems both from the disease, and from possible complications following surgery or medical therapy. In the most serious cases, one hopes to help a patient have sufficient vision to allow successful completion of their schooling so they have the social tools to survive in their own culture. If this is not possible, the price to the patient in quality of life, to his/her family in effort and expense, and the loss to their society can be extremely high. One study of developing world children found a dramatic decrease in life expectancy from suicide in those who were blind. The loss of income and status of a blind person, the dependency of the blind individual on family and society, and the loss of support that the patient might otherwise provide for elderly parents are considerable!!
Long Term Resource Planning
To help pediatric glaucoma patients, particularly those in the developing world, a number of problems must be identified and overcome:
vA critical number of ophthalmologists must be trained to not only perform surgery on children with glaucoma but also participate in the diagnosis, longterm follow-up, and planning mentioned above, in order to maximally benefit affected children and their families. Major centers should ideally have one or more surgeons who are designated as “specialists” in the field of pediatric glaucoma providing significant expertise and experience for the benefit of the community.
vInstruments and supplies must be made available to put such an effective plan into action. The costs for early treatment are small compared to those of advanced disease: a good reason to identify the disease and intervene successfully earlier!
vParents and health planners must be made aware of their responsibilities for surgical follow-up and ongoing medical care.
8
vDoctors, nurses, and other primary health care workers in the patient’s local area should be made aware of the subtleties of glaucoma diagnosis and the need for immediate referral of these patients if definitive treatment is not available locally. The same people should then be made aware of the support needed for families and patients in the local area when patients return home from a treatment center.
vAnesthesia for pediatric patients must be available for children of all ages. Often anesthesiologists lack the experience or skills to attend children of less than 2 - 6 years of age. Absence of this support at an early age can mean guaranteed blindness in pediatric glaucoma patients who could be denied the benefits of timely surgery. Capacity for childhood anesthesia is necessary for both the assessment and the treatment of glaucoma. This includes the need for proper intra-operative and post-operative supervision, facilities, and personnel in both the tertiary care center and the local health facility that will supervise the child upon returning home.
General Characteristics
Causes of Childhood Glaucoma
Glaucoma in the pediatric age group can be divided into roughly 3 subtypes: primary infantile (22%), those with associated systemic conditions (46%), and secondary pediatric glaucoma (32%). Examples of the secondary group are uveitic, post infantile cataract surgery, tumor-related (e.g. retinoblastoma), and angle closure (e.g. retinopathy of prematurity, PHPV). The associated pediatric glaucoma group includes such conditions as Sturge-Weber syndrome, neurofibromatosis (NF-1), Axenfeld-Rieger spectrum, and many other disorders with systemic involvement (Table1)
Figure 1. Primary congenital glaucoma |
Figure 2. Patient with Sturge-Weber |
9
TABLE 1. CHILDHOOD GLAUCOMAS
Developmental Glaucomas
1. Primary congenital glaucoma (PCG)
uNewborn primary congenital glaucoma
uInfantile primary congenital glaucoma
uLate-recognized primary congenital glaucoma
2.Juvenile open-angle glaucoma (JOAG)
3.Primary glaucomas associated with systemic diseases
u8q23.3 deletion S
u9p deletion syndrome
uAicardi-Goutieres syndrome
uAndrogen insensitivity, pyloric stenosis
uBrachmann-deLange syndrome
uCaudal regression syndrome
uCranio-cerebello-cardiac (3C) syndrome
uCutis marmorata telangiectatica congenita
uDiabetes mellitus, polycystic kidneys, hepatic fibrosis, hypothyroidism
uEpidermal Nevus syndrome (Solomon S)
uFetal hydantoin syndrome
uGAPO syndrome
uGlaucoma with microcornea and absent sinuses
uHepatocerebrorenal syndrome (Zellweger)
uInfantile glaucoma with retardation and paralysis
uKniest syndrome (skeletal dysplasia)
uLinear scleroderma
uMarfan syndrome
uMichel's syndrome
uMoyamoya S
uMucopolysaccharidosis
uNail-patella syndrome
uNeurofibromatosis (NF-1)
uNevoid basal cell carcinoma S.(Gorlin S)
uNonprogressive hemiatrophy
uOculocerebrorenal syndrome (Lowe)
uOculodentodigital dysplasia
uPHACE syndrome
uPhakomatosis pigmentovascularis(PPV)
uProteus syndrome
uRieger syndrome
uRoberts' pseudothalidomide syndrome
uRobinow syndrome
uRothmund-Thomson syndrome
uRubinstein-Taybi syndrome
uSHORT syndrome
uSoto syndrome
uStickler syndrome
uSturge-Weber syndrome
uTrisomy 13
uTrisomy 21 (Down syndrome)
uWarburg syndrome
uWolf-Hirschhorn (4p-) syndrome
4.Primary glaucomas with associated ocular anomalies
uAniridia
o congenital aniridic glaucoma o acquired aniridic glaucoma
uAxenfeldRieger anomaly
uCongenital anterior (corneal) staphyloma
uCongenital hereditary endothelial dystrophy
uCongenital iris ectropion syndrome
uCongenital microcoria
uCongenital ocular melanosis
uIdiopathic or familial elevated venous pressure
uIridotrabecular dysgenesis (iris hypoplasia)
uPeters' syndrome
uPosterior polymorphous dystrophy
uSclerocornea
Secondary (Acquired) Glaucomas
1. Traumatic glaucoma
u Acute glaucoma
o Angle concussion o Hyphema
o Ghost cell glaucoma
uGlaucoma related to angle-recession
uArteriovenous fistula
2.Glaucoma with intraocular neoplasms
uAggressive iris nevi
uJuvenile xanthogranuloma (JXG)
uIris rhabdomyosarcoma
uLeukemia
uMedulloepithelioma
uMelanocytoma
uMelanoma of ciliary body
uMucogenic glaucoma with iris stromal cyst
uRetinoblastoma
3.Glaucoma related to chronic uveitis
uAngle-blockage mechanisms
o Synechial angle closure
o Iris bombe with pupillary block
uOpen-angle glaucoma
uTrabecular meshwork endothelialization
4.Lens-related glaucoma
uPhacolytic glaucoma
uSpherophakia with pupillary block
uSubluxation-dislocation with pupillary block o Axial-subluxation high-myopia syndrome o Ectopia lentis et pupillae
o Homocystinuria o Marfan syndrome
o Weill-Marchesani syndrome
5.Glaucoma following lensectomy for congenital cataracts
uInfantile aphakic open-angle glaucoma
uPupillary-block glaucoma
6.Glaucoma related to corticosteroids
7.Glaucoma secondary to rubeosis
uCoats' disease
uFamilial exudative vitreoretinopathy
uMedulloepithelioma
uRetinoblastoma
uSubacute/chronic retinal detachment
8.Angle-closure glaucoma
uCentral retinal vein occlusion
uCicatrical retinopathy of prematurity
uCiliary body cysts
uCongenital pupillary iris-lens membrane
uLaser therapy for threshold ROP
uMicrophthalmos
uNanophthalmos
uPersistent hyperplastic primary vitreous
uRetinoblastoma
uTopiramate therapy
9.Malignant glaucoma
10.Glaucoma associated with increased venous pressure
uCavernous or dural A-V shunt
uOrbital disease
uSturge-Weber syndrome
11.Intraocular infection related glaucoma
uAcute herpetic iritis
uAcute recurrent toxoplasmosis
uEndogenous endophthalmitis
uMaternal rubella infection
12.Glaucoma secondary to unknown etiology
uIridocorneal endothelial syndrome (ICE)
13.Secondary glaucomas associated with hereditary ocular conditions
uEctopia lentis disorders
uPrimary angle-closure glaucoma
uNanophthalmos
uRetinoblastoma
10
Childhood Glaucoma: Signs, Age of Onset, Prognosis
Any glaucoma appearing before 3 years of age may produce enlargement of the cornea and globe (buphthalmos) and often causes clouding of the cornea and photophobia. After age 3 years, the eye will typically not enlarge, but corneal edema or increased cupping may occur and may be the only signs of glaucoma aside from a decrease in functional vision. Most patients with primary infantile glaucoma will present within the first year. Glaucoma presenting at birth has a poorer prognosis with about
50% of children being legally blind in spite of treatment. Glaucoma developing between 3 and 12 months and receiving successful treatment have up to a 90% chance of obtaining good vision. But,
glaucoma can present at any age. Later presentation (e.g. juvenile open angle glaucoma, complicating chronic uveitis) may occur in patients up to 35 years of age or beyond, although it may be confused with adult glaucoma at that point.
Glaucoma associated with Sturge-Weber syndrome, neurofibromatosis, and aniridia may be congenital or present later in childhood or early teens. A thorough knowledge of the natural history of these diseases is necessary to alert the eye care team about the potential onset of glaucoma.
Figure 3. Patient with retinopathy of prematurity (ROP)
Infantile Primary “Congenital” Glaucoma
This is the most commonly thought of diagnosis in the pediatric glaucoma group but it comprises slightly less than about 25% of pediatric glaucomas. It is an hereditary eye disease that usually has no associated primary abnormalities of the eye or body.
Figure 4. Mild primary congenital glaucoma |
Figure 5. Patient with severe untreated |
|
primary congenital glaucoma in a 1-year-old |
11
The incidence of primary infantile glaucoma is said to be about 1 in 10,000 live births and is more common in boys. It is usually, but not exclusively, bilateral.*
Symptoms of pediatric glaucoma:
Photophobia, tearing, reduced vision from cloudy cornea
Signs of pediatric glaucoma:
Enlarged corneas, corneal edema, tearing, photophobia, increased intraocular pressure
(not obligatory during an examination under anesthesia (EUA), abnormal optic nerve cupping, breaks (tears) in Descemet’s membrane (Haab’s striae).
Children with any of the signs and symptoms listed above should be evaluated thoroughly in the clinical setting for glaucoma. As complete a history and examination as possible should be performed before taking the next step - an examination under anesthesia (EUA) - or if suspicion is low, a period of observation. This pediatric glaucoma examination should be carried out in a quiet-supportive atmosphere and with the assistance of parents to obtain as much information as possible.
Examination while the infant is feeding or under minimal sedation creates an environment making possible a more complete examination.
Tonometry and several other steps found on the list mentioned below may be successful. However, when a diagnosis of glaucoma is made or even suspected, an EUA will be necessary. Although the natural tendency is to only take an IOP measurement with a tonometer, this alone is not sufficient to confirm or exclude the diagnosis of glaucoma in the child. Remember, glaucoma may also be only one aspect of a larger problem such as
Figure 7. Haab’s striae
Figure 8. Large glaucomatous cup
* ORBIS experience in southern Ethiopia suggests a higher prevalence, not related to consanguinity, as evidenced by 16 cases of presumed congenital glaucoma being treated in children between age 3 months and 10 years in a 12-month period.
12
